Mpox: Making Vaccination Routine
In this second podcast of our series, hear expert faculty explore the CDC recommendations for mpox protection and discuss how vaccination can lead to immunologic equity. Topics include:Should we consi...
14 Kesä 202413min
Mpox Infection and Prevention
Hear expert faculty answer common questions about the risk, impact, and recommendations for protection against mpox, including:Why is mpox relevant to clinical practice?Who is at highest risk for mpox...
14 Kesä 202419min
Breaking Down Key PrEP Barriers: Patient and Regimen-Based Factors
In this episode, Roger Bedimo, MD, MS, FACP, examines patient and regimen-based PrEP barriers and discusses practical interventions to support PrEP adherence in key populations. Topics covered include...
31 Touko 202411min
Actively Countering Health Disparities to Improve PrEP Uptake
In this episode, Roger Bedimo, MD, MS, FACP, discusses strategies to overcome health disparities to improve PrEP uptake, including:Targeting key populations that would benefit from PrEP but have low r...
31 Touko 202415min
Addressing Provider and Structural PrEP Barriers
In this episode, Roger Bedimo, MD, MS, FACP, examines provider-based and structural PrEP barriers and discusses practical methods for healthcare professionals to overcome these challenges. Topics cove...
31 Touko 202414min
Proactively Considering if Each Person Is on the Right HIV ART Regimen for Them
In this episode, Tristan J. Barber, MA, MD, FRCP, and Roger Bedimo, MD, MS, FACP, help you decide whether and how to modify ART in virologically suppressed individuals by critically appraising whether...
16 Touko 202421min
HIV Monitoring for People Receiving Long Acting PrEP
In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the updated CDC guidance on how to monitor for HIV in people receiving PrEP, including:Rationale for why HIV monitoring differs for peo...
10 Touko 20245min
Studies of LA ART in People With Adherence Challenges or Viremia
In this episode, Jonathan Appelbaum, MD, FACP, AAHIVS, discusses the newest data supporting LA ART use in people with adherence challenges or viremia, including:The LATITUDE study, an open-label phase...
10 Touko 20249min
